Longevity testing can feel like two different worlds at once: a glossy, futuristic one selling "biological age," and a quieter, more boring one built on the blood markers your regular doctor already trusts. This is a plain-language guide to telling them apart before you spend a dollar.
Why "biological age" tests are having a moment
Chronological age is how many years you have lived. "Biological age" is an attempt to estimate how your body is actually functioning — the idea being that two 52-year-olds can age at different rates. The two most-hyped tools are telomere length tests and epigenetic clocks. Both measure something real. Neither is a crystal ball.
It helps to know the underlying biology, because it explains why researchers are excited *and* why cautious clinicians hold back. Aging researchers have described a set of shared cellular changes — often called the "hallmarks of aging" — that include telomere shortening and epigenetic drift, among others [1]. These are legitimate areas of science. The open question is whether measuring them in *you* today changes what a provider would actually do.
Telomere tests: what they measure, what they don't
Telomeres are the protective caps at the ends of your chromosomes. Each time a cell divides, they tend to get a little shorter, and very short telomeres are associated with cellular aging [1][2]. That sounds tidy, and it is why telomere length became an early longevity headline.
The problem is precision and meaning. Telomere length varies a lot between people of the same age, between different cell types, and even between lab methods and blood draws. The U.S. National Institute on Aging notes that while telomere biology is an active research field, telomere length is not a validated way to measure an individual's biological age or predict lifespan in the clinic [2]. In other words: interesting at the population level, shaky as a personal dashboard.
For a cautious newcomer, the honest takeaway is that a telomere number rarely tells a provider to *do* anything specific. It is a research-flavored data point, not a treatment trigger.
Epigenetic clocks: newer, more sophisticated, still research-stage
Epigenetic clocks are the current darling. They look at DNA methylation — small chemical tags on your DNA that change with age and environment — and run those patterns through an algorithm to estimate biological age [1][3]. Multiple generations of these clocks exist, and some correlate with health outcomes across large populations in published research [3].
But correlation across thousands of people is not the same as a reliable, repeatable reading for one person over time. Different clocks can disagree, results can shift with the same sample, and there is no established, evidence-based protocol that says "your clock moved, therefore take X." These are powerful research instruments that are still being validated for individual clinical decision-making [1][3]. A good provider treats an epigenetic age result as context and conversation — not as a diagnosis and not as a prescription.
The panel worth paying for first: proven metabolic and cardiovascular markers
Here is the part that matters most, especially if your budget is finite. The markers with decades of evidence and clear, actionable thresholds are the unglamorous ones — the metabolic and cardiovascular numbers that major medical societies actually build guidelines around.
For cardiovascular risk, LDL cholesterol has extensive, guideline-backed evidence tying it to atherosclerotic disease, and it is a marker clinicians act on directly [4]. Blood pressure categories are defined by the American College of Cardiology and American Heart Association, with a normal reading defined as below 120/80 mmHg [5]. For metabolic and diabetes risk, the American Diabetes Association defines diagnostic ranges for fasting glucose and for hemoglobin A1c — for example, an A1c of 5.7%–6.4% falls in the prediabetes range [6].
The difference is night and day. A telomere or epigenetic result usually ends in "interesting, let's keep an eye on it." An out-of-range LDL, blood pressure, glucose, or A1c ends in a specific, evidence-based conversation about lifestyle and, where appropriate, treatment [4][5][6]. If you are choosing where to start, the proven panel is the panel.
Source: [5] Whelton PK, et al. 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline, [6] American Diabetes Association — Standards of Care: Diagnosis and Classification of Diabetes
% A1c · marker = Diabetes threshold
Source: [6] American Diabetes Association — Standards of Care: Diagnosis and Classification of Diabetes
How a thoughtful provider actually uses aging-clock data
A careful independent provider will not ignore your epigenetic or telomere results — but they also will not build your plan on them. In practice, aging-clock data tends to function as a *motivator and a backdrop*: something reviewed alongside your real, actionable labs, your history, and your goals. The decisions — screening, lifestyle, and any prescription — flow from the validated markers and clinical judgment, not from a biological-age number [2][3].
If you are the type who exports HRV and glucose data into spreadsheets, this is the useful reframe: aging clocks are a fascinating additional layer, but they sit *on top of* a foundation of metabolic and cardiovascular labs that a clinician can interpret against your self-tracking. Bring the data; anchor the decisions to the markers with thresholds.
A note on "not FDA approved" and compounded products
If you have been reading longevity articles, you have seen "not FDA approved" attached to peptides and compounded medications, and it is reasonable to feel uneasy. That phrase is a signal to slow down and involve a licensed provider — not automatically a signal that something is dangerous, but a reason for oversight.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Whether any medication is appropriate — compounded or otherwise — is a decision for an independent licensed provider based on your evaluation, and a prescription is never guaranteed.
How to think about starting, without the pressure
A calm sequence looks like this: begin with the validated metabolic and cardiovascular panel, review it with a licensed provider, and treat aging clocks as optional, exploratory context rather than the main event. Nothing here requires you to order anything injectable, and nothing here is a push toward a specific product. The point of testing is to inform a real clinical conversation.
*This article is educational and not medical advice. It is not a diagnosis or a recommendation to take any specific product. Talk with a licensed provider about your individual situation.*
Source: [2] National Institute on Aging — Do telomeres hold the secret to aging?, [3] Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing (Nature Reviews Genetics), [4] Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol
Where Velri fits
Velri is a technology and coordination company — not a medical provider. Velri can help coordinate lab work and connect you with an independent, licensed provider who reviews your results (including any aging-clock data you bring) in the context of your goals and your validated metabolic and cardiovascular markers. If, and only if, that independent provider determines a prescription is appropriate, it can be filled through an independent licensed pharmacy. Care is always provided by the independent provider; Velri coordinates the experience around it.
